We develop cost effective solutions in the form of biotherapeutics and biosimilars using the E.coli expression system. This enables us to synthesize recombinant proteins at a large scale, with high yield, and with great efficiency, making it the perfect platform for manufacture of biotherapeutics at a commercial scale.

• cGMP E.coli fermentation capacity range: 100, 500, 2000 litres

• State of the art Downstream protein purification set up

• Clinical grade protein and enzyme manufacture at a commercial scale